Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). Higher doses of IVIg are associated with a more insupportable financial burden to pe...
Source: BMC Pediatrics - Category: Pediatrics Authors: Xiangge Ren, Miaomiao Zhang, Xiaohan Zhang, Peidong Zhao and Wensheng Zhai Tags: Research Source Type: research